Medicare Enrolled

Dr. Serge-Alain Awasum, MD

Gastroenterology · Shenandoah, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
9200 PINECROFT DR STE 480, Shenandoah, TX 77380
2812051111
In practice since 2005 (20 years)
NPI: 1164416608 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Awasum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Awasum? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Awasum

Dr. Serge-Alain Awasum is a gastroenterology in Shenandoah, TX, with 20 years in practice. Based on federal Medicare data, Dr. Awasum performed 2,228 Medicare services across 1,361 unique beneficiaries.

Between the years covered by Open Payments, Dr. Awasum received a total of $16,860 from 43 pharmaceutical and/or device companies across 631 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Awasum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 5% volume in TX$ $16,860 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,228
Medicare services
Top 5% in TX for gastroenterology
1,361
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~111 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tissue pathology examination, moderate complexity522$26$197
Office visit, established patient (20-29 min)504$62$170
Special stained specimen slides to identify organisms including interpretation and report251$65$174
Special stained specimen slides to examine tissue including interpretation and report246$53$121
New patient office visit (30-44 min)192$74$250
Colonoscopy with biopsy164$121$740
Upper GI endoscopy with biopsy134$65$490
Removal of polyps or growths of large bowel using an endoscope with mechanical snare54$197$875
Office visit, established patient (30-39 min)45$63$250
Infusion, normal saline solution, 250 cc36$0$20
Colorectal cancer screening; colonoscopy on individual at high risk27$169$625
Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm17$82$495
New patient office visit (45-59 min)13$89$380
Diagnostic exam of large bowel using a flexible endoscope12$139$640
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk11$174$625
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
15.1% medium
83.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,860
Total received (2018-2024)
Avg $2,409/year across 7 years
Top 12% in TX for gastroenterology
43
Companies
631
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,498 (68.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,164 (30.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,268
2023
$1,421
2022
$1,975
2021
$1,480
2020
$992
2019
$7,014
2018
$1,709

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$5,980
ABBVIE INC.
$1,730
AbbVie Inc.
$1,654
Janssen Biotech, Inc.
$937
AbbVie, Inc.
$888
Gilead Sciences, Inc.
$725
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$499
PFIZER INC.
$435
Romark Laboratories, LC
$370
Merck Sharp & Dohme LLC
$320
Apollo Endosurgery US Inc
$306
Celgene Corporation
$275
Janssen Scientific Affairs, LLC
$263
Nestle HealthCare Nutrition Inc.
$212
Ferring Pharmaceuticals Inc.
$187
Merck Sharp & Dohme Corporation
$181
Braintree Laboratories, Inc.
$159
Ardelyx, Inc.
$150
Boston Scientific Corporation
$149
E.R. Squibb & Sons, L.L.C.
$135
QOL Medical, LLC
$133
Intercept Pharmaceuticals, Inc.
$125
Lilly USA, LLC
$111
Shire North American Group Inc
$106
Allergan Inc.
$102
Amgen Inc.
$94
Madrigal Pharmaceuticals
$62
Prometheus Laboratories Inc.
$61
Ethicon US, LLC
$60
Phathom Pharmaceuticals, Inc.
$53
Synergy Pharmaceuticals Inc
$52
GENZYME CORPORATION
$44
Ironwood Pharmaceuticals, Inc
$44
RedHill Biopharma Inc.
$42
Alfasigma USA, Inc.
$40
NESTLE HEALTHCARE NUTRITION INC.
$40
Sandoz Inc.
$30
IRONWOOD PHARMACEUTICALS, INC
$27
UCB, Inc.
$22
Celltrion USA Inc.
$18
AIMMUNE THERAPEUTICS, INC.
$15
VIVUS LLC
$14
Napo Pharmaceuticals Inc
$7
Top 3 companies account for 55.5% of total payments
Associated products mentioned in payments ›
ALINIA · APRISO · AVSOLA · Alinia · Alinia Tablets 500mg 30 count bottle · Alliance II · Amitiza · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · Entyvio · GATTEX · HUMIRA · HYRIMOZ · Humira · IBSRELA · INFLECTRA · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · Motegrity · Mytesi · OCALIVA · OMVOH · Orbera · QSYMIA · REBYOTA · RELISTOR ORAL · REMICADE · RENFLEXIS · RESMETIROM · REZDIFFRA · RINVOQ · Resolution 360 Clip · Resolution 360 ULTRA Clip · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · Sucraid · TREMFYA · TRULANCE · Talicia · Trintellix · Trulance · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFIXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $757 per 100 Medicare services performed
Looking for a gastroenterology in Shenandoah?
Compare gastroenterologys in the Shenandoah area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
83
Per 100K population
12.7
County median income
$97,266
Nearest hospital
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Awasum is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (low-engagement, top 12%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Awasum experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Awasum performed 522 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Awasum receive payments from pharmaceutical companies?
Yes. Dr. Awasum received a total of $16,860 from 43 companies across 631 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Awasum's costs compare to other gastroenterologys in Shenandoah?
Dr. Awasum's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Awasum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →